glp-1 chronic kidney disease Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes GLP-1 Receptor Agonists in Chronic
Description
semaglutide has a longer track record
Available from: Hamed K, Alosaimi MN, Ali BA, Alghamdi A, Alkhashi T, Alkhaldi SS, et al
For someone on a GLP-1 medication, this is invaluable data
In an unusual move, GLP manufacturers have asked for vision loss lawsuits to be consolidated in a group litigation called a multidistrict litigation
Targeting No
Some content is produced with paid support from a third party, however our editorial decisions remain independent
